BOPA Abstract deadline EXTENDED TO 9am Monday 10th August 2020

You spoke – we listened

The deadline for abstracts for this year’s virtual conference has been extended. Delegates are invited to present results of their clinical and technical work as a poster with some selected for oral presentation. The author/s should submit via the BOPA website by 9am Monday 10th August 2020. Abstracts will be reviewed and marked by the BOPA Audit and Research Sub-Committee, and chosen authors will be invited to display their poster for the duration of the conference, with the posters achieving high scores selected for oral presentation.

Selected abstracts will be published in a supplement to the Journal of Oncology Pharmacy Practice (JOPP), providing authors with a citation in a peer reviewed journal. The winning presentation will receive a prize worth £2,000 to attend an international conference.

Further information can be found on the abstract section of the website HERE.

Late Breaking Abstracts: This year we will allow delegates to submit late breaking abstracts. Abstracts relating to the Covid-19 pandemic will be considered for presentation by the research committee if completed work is submitted after the 10th August deadline. Please contact the A&R committee to request a late submission relating to Covid-19.

Latest News

By UK SACT Board Representatives - Joseph Williams and Netty Cracknell on 16th September 2025

Proposals for the reshaping of cancer services in England: funding for innovative cancer treatments

The Royal College of Radiologists (RCR) and the Society of Radiographers (SoR) have published a short document that expands on previous proposals for improving funding arrangements to enable equitable access…

Read article
By BOPA Exec Committee on 15th September 2025

Invitation to visit the BOPA stand at the BOPA Conference in Belfast

Hello All As an Executive Committee we are looking forward to meeting those of you who are signed up to come to the conference in Belfast next month. The BOPA…

Read article
By BOPA Research subcommittee on 14th September 2025

Survey: Fertility and the use of Immune Checkpoint Inhibitor Therapy (Survey from Royal Marsden Hospital)

Immune checkpoint inhibitors, such as atezolizumab, nivolumab and pembrolizumab have transformed the treatment landscape for many cancers. Cancers such as melanoma and Lynch-syndrome related tumours necessitating immune checkpoint inhibitors are…

Read article
By Clayton Wong on 8th September 2025

British Oncology Pharmacy Association (BOPA) invites you to Clinical Pharmacy Congress North 2025

British Oncology Pharmacy Association (BOPA) invites you to Clinical Pharmacy Congress North 21-22 November 2025 | Manchester Central Confirm your free delegate place *free places are only available for registered healthcare…

Read article